Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BSR and BHPR guideline for the treatment of systemic sclerosis.
Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, Fligelstone K, Gompels LL, Griffiths B, Herrick AL, Pang J, Parker L, Redmond A, van Laar J, Warburton L, Ong VH; BSR and BHPR Standards, Guidelines and Audit Working Group. Denton CP, et al. Among authors: redmond a. Rheumatology (Oxford). 2016 Oct;55(10):1906-10. doi: 10.1093/rheumatology/kew224. Epub 2016 Jun 9. Rheumatology (Oxford). 2016. PMID: 27284161 Free article. Review. No abstract available.
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol.
Alcacer-Pitarch B, Buch MH, Gray J, Denton CP, Herrick A, Navarro-Coy N, Collier H, Loughrey L, Pavitt S, Siddle HJ, Wright J, Helliwell PS, Emery P, Redmond AC. Alcacer-Pitarch B, et al. Among authors: redmond ac. BMC Musculoskelet Disord. 2012 Feb 6;13:11. doi: 10.1186/1471-2474-13-11. BMC Musculoskelet Disord. 2012. PMID: 22309847 Free PMC article. Clinical Trial.
The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug.
Navarro Coy NC, Brown S, Bosworth A, Davies CT, Emery P, Everett CC, Fernandez C, Gray JC, Hartley S, Hulme C, Keenan AM, McCabe C, Redmond A, Reynolds C, Scott D, Sharples LD, Pavitt S, Buch MH. Navarro Coy NC, et al. Among authors: redmond a. BMC Musculoskelet Disord. 2014 Dec 23;15:452. doi: 10.1186/1471-2474-15-452. BMC Musculoskelet Disord. 2014. PMID: 25539805 Free PMC article. Clinical Trial.
Recommendations for the conduct of efficacy trials of treatment devices for osteoarthritis: a report from a working group of the Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Group.
Felson DT, Redmond AC, Chapman GJ, Smith TO, Hamilton DF, Jones RK, Holt CA, Callaghan MJ, Mason DJ; Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Group; Conaghan PG. Felson DT, et al. Among authors: redmond ac. Rheumatology (Oxford). 2016 Feb;55(2):320-6. doi: 10.1093/rheumatology/kev328. Epub 2015 Sep 10. Rheumatology (Oxford). 2016. PMID: 26361882 Free PMC article. Review.
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group.
Chapman LS, Alcacer-Pitarch B, Pauling JD, Flurey CA, Redmond AC, Richards P, Herrick AL, Merkel PA, Proudman S, Menz HB, Helliwell PS, Hannan MT, Domsic RT, Saketkoo LA, Shea B, Siddle HJ. Chapman LS, et al. Among authors: redmond ac. Semin Arthritis Rheum. 2024 Apr;65:152372. doi: 10.1016/j.semarthrit.2024.152372. Epub 2024 Feb 2. Semin Arthritis Rheum. 2024. PMID: 38325052 Free article.
466 results